Commercial Success of ADHD Drug
This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Background
A number of generic drug companies sought FDA approval to market generic versions of a branded ADHD drug prior to the expiration of patents covering the branded drug. The generic drug companies filed Abbreviated New Drug Applications and Paragraph IV certifications asserting that patents covering the branded drug were invalid or not infringed. In response, the branded drug company filed claims of patent infringement against the generic drug companies.
Our Analysis
Intensity provided an expert report, deposition testimony, and trial testimony relating to an evaluation of the commercial success of patents covering the branded drug. As part of addressing patent validity, the court considered the testimony of a Intensity expert on whether the patented invention had been a commercial success.
Intensity analyzed economic issues involving market definition, commercial performance, and long-felt need in the marketplace. Intensity performed economic analysis to evaluate sales and market share of the branded drug among competing drugs in the marketplace. In addition, we organized and processed complex data and presented its findings from the data analysis at trial.
Intensity analyzed a number of economic issues to inform on whether commercial performance of the branded drug was driven by the patents-in-suit or other economic factors. These issues included pricing, discounting, profitability, marketing, and other potential drivers of sales. Intensity also evaluated the economic impact of marketing materials that FDA had found to be false and misleading to consumers.
Latest Insights
Article | January 31, 2025
UK Corporate Crime Law Puts ‘Senior Managers’ in the Hot Seat
The UK’s Economic Crime and Corporate Transparency Act (ECCTA) is a game-changer for corporate accountability. By broadening liability for fraud and redefining “senior manager,” it signals a clear warning: organisations will be held accountable for the actions of their staff and, potentially, those of third parties. Whilst ECCTA presents significant challenges, it also offers opportunities […]
News | January 30, 2025
Integrity and Accountability: Anti-Corruption Enforcement in Saudi Arabia
As Saudi Arabia advances its transformative Vision 2030 agenda, the country’s blueprint for economic and long-term prosperity, it is placing a strong emphasis on accountability and integrity through combating bribery and corruption. In our latest whitepaper, we explore the legislative developments and impacts of these initiatives on fostering a governance framework aligned with Vision 2030.
See All Insights
Talk to Our Insightful Experts